N-(tert-Butyl)-7-methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-sulfonamide

Catalog No. :
ACFSFY677
CAS No. :
727672-14-2
Molecular Formula :
C13H18N2O4S
Molecular Weight :
298.36

IUPAC Name:N-(tert-butyl)-7-methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-sulfonamide

N-(tert-Butyl)-7-methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-sulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$188.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(tert-Butyl)-7-methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-sulfonamide
IUPAC NameN-(tert-butyl)-7-methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-sulfonamide
MDL No.MFCD05860259
Molecular FormulaC13H18N2O4S
Molecular Weight298.36
SMILESO=S(C1=C(C)C=C(OCC(N2)=O)C2=C1)(NC(C)(C)C)=O
InChI KeyWFSMBPYVTMVWEK-UHFFFAOYSA-N
SynonymN-(tert-butyl)-7-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide;N-(tert-butyl)-7-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamideMFCD05860259
CAS No.727672-14-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACFSFY677 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPLCQ651 route compound structure diagram
    ACPLCQ65160469-70-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFSFY677 route product structure diagram
    ACFSFY677727672-14-2
Inquiry

2. ACFSFY677 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPLCQ651 route compound structure diagram
    ACPLCQ65160469-70-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFSFY677 route product structure diagram
    ACFSFY677727672-14-2
Inquiry

Comments (0)